News Articles Tagged: Cushing's Syndrome

Sourcing Trilostane (CAS 13647-35-3): A Guide for Pharmaceutical Manufacturers

A comprehensive guide for pharmaceutical manufacturers on sourcing Trilostane, a high-purity pharmaceutical intermediate essential for treating conditions like Cushing's syndrome.

Understanding Trilostane: A Key Pharmaceutical Intermediate for Endocrine Health

Explore the role of Trilostane (CAS 13647-35-3) as a critical pharmaceutical intermediate in treating endocrine disorders like Cushing's syndrome and aldosteronism. Learn about its mechanism and applications.

Navigating Mifepristone: A Guide for Healthcare Professionals and Patients

Providing essential information on Mifepristone, including its usage in medical abortion and Cushing's syndrome, safety considerations, and regulatory aspects.

The Evolving Landscape of Mifepristone: From Development to Global Access

Explore the comprehensive history, pharmacological advancements, and current accessibility challenges of Mifepristone, a key medication in reproductive health and endocrine treatment.